353 related articles for article (PubMed ID: 24535916)
21. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
22. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
23. Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome.
Xue H; Chen C; Li W; Lin C; Fang J; Li Y; Xu H
Minerva Pediatr; 2015 Jun; 67(3):251-61. PubMed ID: 25941132
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010.
Imashuku S
J Pediatr Hematol Oncol; 2011 Jan; 33(1):35-9. PubMed ID: 21088619
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
Huang J; Yin G; Duan L; Tian T; Xu J; Wang J; Gao X; Cheng W; Liu L; Qiu H
J Clin Immunol; 2020 Jul; 40(5):718-728. PubMed ID: 32495220
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
[TBL] [Abstract][Full Text] [Related]
27. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
30. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
[TBL] [Abstract][Full Text] [Related]
31. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of Virology and Immune Inflammation of Epstein-Barr Virus Infection Related Non-Neoplastic Diseases in Children.
Wang Q; Duan Z; Duan W; Ruan M; Zhang Y; Zhang H; Zhou Q
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747912
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis.
Cai L; Xing Y; Xia Y; Zhang Z; Luo Z; Tang Y; Chen Y; Xu X
BMC Infect Dis; 2023 Oct; 23(1):728. PubMed ID: 37880605
[TBL] [Abstract][Full Text] [Related]
34. Hemophagocytic lymphohistiocytosis secondary to Epstein Barr virus and Leishmania co-infection in a toddler.
DomInguez-Pinilla N; Baro-Fernández M; González-Granado LI
J Postgrad Med; 2015; 61(1):44-5. PubMed ID: 25511219
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan.
Yanagisawa R; Nakazawa Y; Matsuda K; Yasumi T; Kanegane H; Ohga S; Morimoto A; Hashii Y; Imaizumi M; Okamoto Y; Saito AM; Horibe K; Ishii E;
Int J Hematol; 2019 Feb; 109(2):206-213. PubMed ID: 30535855
[TBL] [Abstract][Full Text] [Related]
36. Dermatopathic lymphadenitis with generalized erythroderma in a patient with epstein-barr virus-associated hemophagocytic lymphohistiocytosis.
Lee WJ; Lee DW; Kim CH; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Am J Dermatopathol; 2010 Jun; 32(4):357-61. PubMed ID: 20010284
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
38. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.
Imashuku S; Hibi S; Ohara T; Iwai A; Sako M; Kato M; Arakawa H; Sotomatsu M; Kataoka S; Asami K; Hasegawa D; Kosaka Y; Sano K; Igarashi N; Maruhashi K; Ichimi R; Kawasaki H; Maeda N; Tanizawa A; Arai K; Abe T; Hisakawa H; Miyashita H; Henter JI
Blood; 1999 Mar; 93(6):1869-74. PubMed ID: 10068659
[TBL] [Abstract][Full Text] [Related]
39. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.
Zhu M; Zhang J; Shi Q; Sun X; Wang H; Sun M; Liu Y
Iran J Immunol; 2023 Dec; 20(4):466-472. PubMed ID: 37873944
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center.
Imashuku S; Kuriyama K; Sakai R; Nakao Y; Masuda S; Yasuda N; Kawano F; Yakushijin K; Miyagawa A; Nakao T; Teramura T; Tabata Y; Morimoto A; Hibi S
Med Pediatr Oncol; 2003 Aug; 41(2):103-9. PubMed ID: 12825212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
